Concepedia

Author

Betty K. Hamilton

Cleveland ClinicORCID

Also Known As

B Hamilton, B K Hamilton, B. Hamilton, B.K. Hamilton, BK Hamilton, Betty Hamilton, Betty K Hamilton, Betty K. Hamilton, Betty Ky Hamilton, Liesveld, Jane

487

Publications

4.6K

Citations

36

H-Index

87

Concepts

All Affiliations

Cleveland ClinicFred Hutch Cancer CenterMoffitt Cancer CenterMedical College of WisconsinVanderbilt University Medical Center
BK

About

Betty K. Hamilton is an author at Cleveland Clinic specializing in medicine, transplantation, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

27

797

2

Health Sciences

8

8

206

3

Education

1

1

21

4

Engineering

1

1

70

5

Nursing

1

1

46

Betty K. Hamilton

×

86

Publications

3.1K

Citations

32

H-Index

YearCitations

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Edward A. Copelan, Betty K. Hamilton, Belinda R. Avalos,

Blood

2013

182

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala,

Transplantation and Cellular Therapy

2021

165

Biomarker Panel for Chronic Graft-Versus-Host Disease

Jeffrey Yu, Barry E. Storer, Kushi Kushekhar,

Journal of Clinical Oncology

2016

129

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium

Zachariah DeFilipp, Amin M. Alousi, Joseph A. Pidala,

Blood Advances

2021

124

Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network

Xiaorong Gu, Rita Tohmé, Benjamin Tomlinson,

Leukemia

2020

99

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia

Partow Kebriaei, Claudio Anasetti, Mei‐Jie Zhang,

Biology of Blood and Marrow Transplantation

2017

97

Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes

Yogen Saunthararajah, Mikkael A. Sekeres, Anjali S. Advani,

Journal of Clinical Investigation

2015

88

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Brian C. Shaffer, Kwang Woo Ahn, Zhen‐Huan Hu,

Journal of Clinical Oncology

2016

74

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors

Guru Subramanian Guru Murthy, Soyoung Kim, Zhen‐Huan Hu,

JAMA Oncology

2022

73

Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes

Aziz Nazha, Karam Al-Issa, Betty K. Hamilton,

Leukemia

2017

70

Page 1